12 October 2016 - HAS has published the agenda for the next scheduled Transparency Commission meeting. ...
27 September 2016 - CSL Behring's Idelvion is now approved by the TGA. ...
19 September 2016 - The Transparency Commission will consider the reimbursement of a number of new medicines and blood products. ...
15 September 2016 - The TGA has approved a new use for Biogen's Alprolix. ...
14 September 2016 - Approval follows positive data from clinical studies on efficacy and tolerability, as well as infusion time and ...
1 August 2016 - New system reduces number of steps in the treatment process for haemophilia A patients on Adynovate [antihemophilic ...
29 Jul 2016 - ADMA Biologics announced that the U.S. FDA has issued a complete response letter to the company’s biologics ...
15 July 2016 - The Transparency Commission will consider the reimbursement of new medicines and blood products. ...
30 June 2016 - The Transparency Commission will consider the reimbursement of new medicines and blood products. ...
17 June 2016 - The TGA has published an AusPAR for Octapharma's Nuwiq (simoctocog alfa). ...
15 June 2016 - Glassia is the only FDA approved alfa-1 antitrypsin (human) augmentation treatment that patients can self-infuse at home. ...
1 June 2016 - The Transparency Commission will consider the (continued) reimbursement of dexketoprofen with tramadol hydrochloride (Skudexum), empagliflozin (Jardiance), plasma ...
31 May 2016 - The EMA has published an EPAR for albutrepenonacog alfa (Idelvion). ...
26 May 2016 - CSL today announced that the US FDA has approved Afstyla [anti-haemophilic factor (recombinant), single chain], CSL Behring’s ...
25 May 2016 - The EMA has published an EPAR for eftrenonacog alfa (Alprolix). ...